Penn State’s Collins To Speak on Behavioral
Interventions, Mar. 26 at Natcher Bldg.
Dr. Linda Collins, director of the Methodology Center and professor, department of statistics and department of human development and family studies at Pennsylvania State University, will speak at NIH on Tuesday, Mar. 26 from 10 a.m. to noon in Bldg. 45, balcony B. Her talk, “Raising the Bar: Engineering Optimized Behavioral Interventions for Increased Public Health Impact,” is part of the NIH Office of Disease Prevention’s Medicine: Mind the Gap seminar series.
Collins will discuss why behavioral interventions are important in many areas of public health, for example, smoking cessation, drug abuse prevention, treatment of obesity, management of heart failure symptoms and promotion of physical activity. She will review an approach called multiphase optimization strategy (MOST), an engineering-inspired framework for developing, optimizing and evaluating behavioral interventions.
Since 1996, Collins has been director of a National Institute on Drug Abuse Center of Excellence, the Center for Prevention and Treatment Methodology. Her research also is funded by NCI and NIDDK.
The seminar is cosponsored by the National Institute on Alcohol Abuse and Alcoholism. Registration is not required; seating is on a first-come, first-served basis. Sign language interpreters will be provided. Those who require reasonable accommodation to participate should email Paris.Watson@nih.gov or call her at (301) 496-6615.
STEP Forum on Behavior Change, Apr. 4
The staff training in extramural programs (STEP) committee will present a Science in the Public Health forum on the topic “Behavior Change: Why Is It So Hard?” on Thursday, Apr. 4, from 9 to 11 a.m. in Lister Hill Auditorium, Bldg. 38A.
Does someone you know have a bad habit you wish they would change? Do you? Bad habits are like a comfortable chair, easy to get into, but hard to get out of. Why is it so difficult to change a behavior and adopt healthier habits? Come and learn the conditions, characteristics and mechanisms to bring about and maintain change.
Symposium on Gluten Disorders Set, Mar. 22
In honor of National Nutrition Month, the NIH Division of Nutrition Research Coordination is sponsoring a mini-symposium, “Gluten Disorders: Scientific, Dietary and Consumer Education Perspectives.”
The meeting will be held in Masur Auditorium, Bldg. 10 on Friday, Mar. 22 from 8:30 a.m. to 12:45 p.m. It will feature oral presentations and a panel discussion. Topics include historical analyses of wheat gluten content, epidemiological and clinical perspectives on the diagnosis and management of gluten disorders, the status of FDA’s gluten-free food labeling rulemaking and challenges/opportunities for managing a gluten-free diet.
See the agenda at http://dnrc.nih.gov/glutenDisorders.asp. Online pre-registration is required (http://citfm.cit.nih.gov/dnrc/dnrcregistration.php). Questions about the program may be directed to DNRC@nih.hhs.gov.
Next Protocol Navigation Lecture, Apr. 1
The IRP Protocol Navigation Training Program Seminar Series continues with a lecture to be held Monday, Apr. 1 from 2 to 3 p.m. in Lipsett Amphitheater, Bldg. 10. The program is a trans-NIH effort to develop resources and tools and to provide training for intramural staff and contractors involved in protocol development, writing, coordination and management. Dr. James Cimino of the Clinical Center will present “Meeting Data Access and Reporting Requirements with the NIH’s Biomedical Translational Research Information System (BTRIS).” For more information, contact Beverly Barham, (301) 594-2494, email@example.com or Marcia Vital, (301) 451-9437, firstname.lastname@example.org.
Cancer Immunotherapy Clinical Trials Workshop, Apr. 4-5
The Society for Immunotherapy of Cancer is offering a 2-day workshop, Cancer Immunotherapy Clinical Trials: Concepts and Challenges, on Apr. 4-5 from 8 a.m. to 5 p.m. in Masur Auditorium, Bldg. 10. The workshop will outline current challenges posed by development of therapeutic trials in immunotherapy. Several issues will be examined: preclinical testing requirements for clinical development, innovative clinical trial design, appropriate patient selection, end-point determination and developing combination therapies to improve long-term disease management and survival. Accelerating anticancer agent development, validation and approvals will also be discussed. The program is free to government employees but registration is required. For more information, visit http://www.sitcancer.org/sitc-meetings/cict13.
NLM Spring Lecture Series Continues
The NLM spring lecture series continues Wednesday, Mar. 27, 3:30-6 p.m., in Lister Hill Auditorium, Bldg. 38A. Speakers will be Dr. Nancy Harrington, professor and associate dean for research, department of communication, College of Communication and Information, University of Kentucky; and Dr. Linda Neuhauser, clinical professor of community health and human development and co-principal investigator of health research for action, School of Public Health, University of California, Berkeley. The public is invited.
For the complete series schedule, visit www.nlm.nih.gov/news/com_lecture_kreps.html.